安徽医科大学学报

参考文献

[1] Singh O P.Comprehensive mental health action plan 2013–2030:we must rise to the challenge[J].Indian J Psychiatry,2021,63(5):415-7.

[2] Caulfield A,Vatansever D,Lambert G,et al.WHO guidance on mental health training:a systematic review of the progress for non-specialist health workers[J].BMJ Open,2019,9(1):e024059.

[3] Huang Y,Wang Y,Wang H,et al.Prevalence of mental disorders in China:a cross-sectional epidemiological study[J].Lancet Psychiatry,2019,6(3):211-24.

[4] Beurel E,Toups M,Nemeroff C B.The bidirectional relationship of depression and inflammation:double trouble[J].Neuron,2020,107(2):234-56.

[5] 徐永君，盛慧，倪鑫.抑郁症发病机制研究进展[J].安徽医科大学学报，2012,47(3):323-6.

[6] Taler M,Aronovich R,Henry Hornfeld S,et al.Regulatory effect of lithium on hippocampal blood-brain barrier integrity in a rat model of depressive-like behavior[J].Bipolar Disord,2021,23(1):55-65.

[7] Costi S,Morris L S,Collins A,et al.Peripheral immune cell reactivity and neural response to reward in patients with depression and anhedonia[J].Transl Psychiatry,2021,11(1):565.

[8] Kappelmann N,Arloth J,Georgakis M K,et al.Dissecting the association between inflammation,metabolic dysregulation,and specific depressive symptoms:a genetic correlation and 2-sample mendelian randomization study[J].JAMA Psychiatry,2021,78(2):161-70.

[9] Lindqvist D,Dhabhar F S,James S J,et al.Oxidative stress,inflammation and treatment response in major depression[J].Psychoneuroendocrinology,2017,76:197-205.

[10] Cheon S Y,Lee J E.Extracellular vesicles and immune system in ageing and immune diseases[J].Exp Neurobiol,2021,30(1):32-47.

[11] Tang W,Liu H,Chen L,et al.Inflammatory cytokines,complement factor H and anhedonia in drug-na?ve major depressive disorder[J].Brain Behav Immun,2021,95:238-44.

[12] Gibson C L,Bassir Nia A,Spriggs S A,et al.Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity[J].Psychiatry Res,2020,293:113380.

[13] Zhang K,Sakamoto A,Chang L,et al.Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress:beneficial effects of (R)-ketamine[J].Eur Arch Psychiatry Clin Neurosci,2021,271(3):447-56.

[14] Sharon G,Sampson T R,Geschwind D H,et al.The central nervous system and the gut microbiome[J].Cell,2016,167(4):915-32.

[15] Medina-Rodriguez E M,Lowell J A,Worthen R J,et al.Involvement of innate and adaptive immune systems alterations in the pathophysiology and treatment of depression[J].Front Neurosci,2018,12:547.

[16] Torres-Platas S G,Cruceanu C,Chen G G,et al.Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides[J].Brain Behav Immun,2014,42:50-9.

[17] Ahmetspahic D,Schwarte K,Ambrée O,et al.Altered B cell homeostasis in patients with major depressive disorder and normalization of CD5 surface expression on regulatory B cells in treatment responders[J].J Neuroimmune Pharmacol,2018,13(1):90-9.

[18] Schiweck C,Valles-Colomer M,Arolt V,et al.Depression and suicidality:a link to premature T helper cell aging and increased Th17 cells[J].Brain Behav Immun,2020,87:603-9.

[19] Hassamal S.Chronic stress,neuroinflammation,and depression:an overview of pathophysiological mechanisms and emerging anti-inflammatories[J].Front Psychiatry,2023,14:1130989.

[20] Mazza M G,De Lorenzo R,Conte C,et al.Anxiety and depression in COVID-19 survivors:role of inflammatory and clinical predictors[J].Brain Behav Immun,2020,89:594-600.

[21] Arioz B I,Tastan B,Tarakcioglu E,et al.Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1/Nrf2 pathway[J].Front Immunol,2019,10:1511.

[22] Adams T B,Wharton C M,Quilter L,et al.The association between mental health and acute infectious illness among a national sample of 18- to 24-year-old college students[J].J Am Coll Health,2008,56(6):657-63.

[23] Andersson N W,Goodwin R D,Okkels N,et al.Depression and the risk of severe infections:prospective analyses on a nationwide representative sample[J].Int J Epidemiol,2016,45(1):131-9.

[24] Dai Y X,Tai Y H,Chang Y T,et al.Association between major depressive disorder and subsequent autoimmune skin diseases:a nationwide population-based cohort study[J].J Affect Disord,2020,274:334-8.

[25] Brasanac J,Ramien C,Gamradt S,et al.Immune signature of multiple sclerosis-associated depression[J].Brain Behav Immun,2022,100:174-82.

[26] K?hler-Forsberg O,N Lydholm C,Hjorth?j C,et al.Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms:meta-analysis of clinical trials[J].Acta Psychiatr Scand,2019,139(5):404-19.

[27] Kotkowska Z,Strzelecki D.Depression and autoimmune hypothyroidism-their Relationship and the effects of treating psychiatric and thyroid disorders on changes in clinical and biochemical parameters including BDNF and other cytokines-a systematic review[J].Pharmaceuticals (Basel),2022,15(4):391.

[28] Wang X,Zhang L,Lei Y,et al.Meta-analysis of infectious agents and depression[J].Sci Rep,2014,4(1):4530.

[29] Vindegaard N,Petersen L V,Lyng-Rasmussen B I,et al.Infectious mononucleosis as a risk factor for depression:a nationwide cohort study[J].Brain Behav Immun,2021,94:259-65.

[30] K?hler C A,Freitas T H,Stubbs B,et al.Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder:systematic review and meta-analysis[J].Mol Neurobiol,2018,55(5):4195-206.

[31] Chen C Y,Yeh Y W,Kuo S C,et al.Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder[J].Psychoneuroendocrinology,2018,87:108-18.

[32] Fornaro M,Rocchi G,Escelsior A,et al.Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds[J].J Affect Disord,2013,145(3):300-7.

[33] Brunoni A R,Machado-Vieira R,Zarate C A,et al.Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS):results from a factorial,randomized,controlled trial[J].Psychopharmacology (Berl),2014,231(7):1315-23.

[34] Mosio?ek A,Pi?ta A,Jakima S,et al.Effects of Antidepressant treatment on peripheral biomarkers in patients with major depressive disorder (MDD)[J].J Clin Med,2021,10(8):1706.

[35] Zheng P,Zeng B,Zhou C,et al.Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism[J].Mol Psychiatry,2016,21(6):786-96.

[36] Nikolova V L,Smith M R B,Hall L J,et al.Perturbations in gut microbiota composition in psychiatric disorders:a review and meta-analysis[J].JAMA Psychiatry,2021,78(12):1343-54.

[37] Sanada K,Nakajima S,Kurokawa S,et al.Gut microbiota and major depressive disorder:a systematic review and meta-analysis[J].J Affect Disord,2020,266:1-13.

[38] Lightman S L,Birnie M T,Conway-Campbell B L.Dynamics of ACTH and cortisol secretion and implications for disease[J].Endocr Rev,2020,41(3):bnaa002.

[39] Sforzini L,Nettis M A,Mondelli V,et al.Inflammation in cancer and depression:a starring role for the kynurenine pathway[J].Psychopharmacology (Berl),2019,236(10):2997-3011.

[40] Keller J,Gomez R,Williams G,et al.HPA axis in major depression:cortisol,clinical symptomatology and genetic variation predict cognition[J].Mol Psychiatry,2017,22(4):527-36.

[41] Rimti F H,Shahbaz R,Bhatt K,et al.A review of new insights into existing major depressive disorder biomarkers[J].Heliyon,2023,9(8):e18909.

[42] Hodes G E,Kana V,Menard C,et al.Neuroimmune mechanisms of depression[J].Nat Neurosci,2015,18(10):1386-93.

[43] Wang A K,Miller B J.Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients:comparisons between schizophrenia,bipolar disorder,and depression[J].Schizophr Bull,2018,44(1):75-83.

[44] Enache D,Pariante C M,Mondelli V.Markers of central inflammation in major depressive disorder:a systematic review and meta-analysis of studies examining cerebrospinal fluid,positron emission tomography and post-mortem brain tissue[J].Brain Behav Immun,2019,81:24-40.

[45] O’Connor J C,Lawson M A,André C,et al.Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice[J].Mol Psychiatry,2009,14(5):511-22.